Does PFMT help urinary leakage?
Pelvic-floor muscle training (PFMT) is supported as a first-line treatment for women with stress urinary incontinence. The strongest findings concern leakage with coughing, exertion or movement; they do not establish the same certainty for urgency-only leakage.
This review checks three public sources on 9 October 2026. Their research search dates are earlier than this page’s revision date.
The treatment-versus-control evidence
The 2018 Cochrane review included 31 trials and 1817 women. It compared PFMT with no treatment or inactive controls and searched studies through 12 February 2018.
In four trials involving 165 women with stress incontinence, 56% assigned to PFMT reported cure at the end of treatment, compared with 6% in controls. Cochrane rated this particular result high certainty. These are study proportions, not a personal chance of cure. Other outcomes and populations had lower certainty, and most follow-up lasted less than 12 months.
The review found reduced leakage frequency and improved symptoms. It included only one urgency-only study and one mixed-incontinence study; neither supplied cure data for those subgroups. A finding combining different incontinence types cannot fill that gap.
Does the evidence identify the best way to train?
The 2024 Cochrane review of PFMT approaches asked a different question: which exercise type, dose or delivery method works better? Its search ended on 27 September 2023; 63 trials included 4920 women, predominantly with stress or stress-predominant mixed leakage.
For incontinence-related quality of life, individual supervision probably differed little from group supervision. Many other delivery and dose comparisons had low or very low certainty. The review excluded pregnant, recently postpartum and neurological populations. It therefore supplies neither one proven contraction schedule nor evidence that an independent timer replaces assessment. Its e-health comparison involved communication with clinicians, which PelvicEx does not provide.
How guidelines translate this into care
NICE NG123, recommendation 1.4.4, recommends at least three months of supervised PFMT as first-line treatment for stress or mixed incontinence. This is a care recommendation, not a claim that every trial found the same benefit or that every person should start identical exercises.
A useful assessment identifies the leakage pattern and checks contraction and relaxation. Track the outcome that matters to you, such as fewer leakage episodes during a particular activity. If symptoms do not improve, ask for a review of diagnosis, technique and the treatment plan rather than automatically squeezing harder.
What PelvicEx can support
PelvicEx can time an agreed exercise plan and store completion records locally. It cannot diagnose the leakage subtype, verify technique or reproduce clinician supervision. None of the sources above evaluates PelvicEx itself.
Pain, difficulty relaxing or emptying the bladder, bleeding or worsening symptoms need assessment before progressing. Pregnancy, recent pelvic surgery and prescribed care require their own restrictions. Seek urgent care for sudden inability to urinate, major bleeding, severe rapidly worsening pain, fever with marked illness, or new saddle/genital numbness with acute bladder, bowel or leg changes.
Related guides
For practical context, read stress urinary incontinence, mixed urinary incontinence and urinary incontinence assessment boundaries.
Sources
- Dumoulin C, Cacciari LP, Hay-Smith EJC. PFMT versus no treatment or inactive controls for urinary incontinence in women. Cochrane, 2018. DOI: 10.1002/14651858.CD005654.pub4. Review and results.
- Hay-Smith EJC et al. Comparisons of approaches to PFMT for urinary incontinence in women. Cochrane, 2024. DOI: 10.1002/14651858.CD009508.pub2. Indexed abstract.
- NICE. Urinary incontinence and pelvic organ prolapse in women: management, NG123. Recommendations.